http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-706154-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81c150af8961fd5ae4f74c3565019f3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0026d3b75c46d7c5157b131716f3603
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_310b435a9056e68befb37b5cfc53ddd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc44a3e30f5b25197450a24c4ab082b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c91d6e33e549ee73591d69163afd077c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9a2343c89b74142c5463c475c7d8c83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaeb2622c99de3d3a6c18a463b010406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e023cc77c934047a62905dc330e41c
publicationDate 2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-706154-A
titleOfInvention 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
abstract Disclosed herein is the compound 1-(3-Tert-butyl-1-phenyl-1H-pyrazol-5-yl)-3-(4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)naphthalen-1-yl)urea and phenyl substituted derivatives thereof and their use in the treatment of cancer, including pancreatic cancer; thyroid cancer; colorectal cancer; seminoma; myelodysplastic syndrome (MDS); lung cancer; liver cancer; leukemia; melanoma; bladder cancer; kidney cancer; breast cancer, ovarian cancer, bile duct cancer, or glioma.
priorityDate 2010-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53310623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419904863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46198316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419904975

Total number of triples: 29.